Biomarker discovery

Results: 156



#Item
1XenTech patient-derived xenograft (PDX) panels: a clinically relevant platform for drug efficacy , target validation and predictive biomarker discovery studies. Pascal Leuraud, Stefano Cairo, Olivier Déas, Marie-France

XenTech patient-derived xenograft (PDX) panels: a clinically relevant platform for drug efficacy , target validation and predictive biomarker discovery studies. Pascal Leuraud, Stefano Cairo, Olivier Déas, Marie-France

Add to Reading List

Source URL: www.xentech.eu

Language: English - Date: 2015-12-22 11:05:04
    2JANOUSOVA et al.: BIOMARKER DISCOVERY FOR SPARSE CLASSIFICATION OF IMAGES Annals of the BMVA Vol. 2012, No. 2, pp 1–Biomarker discovery for sparse

    JANOUSOVA et al.: BIOMARKER DISCOVERY FOR SPARSE CLASSIFICATION OF IMAGES Annals of the BMVA Vol. 2012, No. 2, pp 1–Biomarker discovery for sparse

    Add to Reading List

    Source URL: www.bmva.org

    Language: English - Date: 2012-09-14 07:15:06
      3In cooperation with Rudolf Öhler / Gerald Stübiger Project Leaders MALDI-MS CBmed Contact:

      In cooperation with Rudolf Öhler / Gerald Stübiger Project Leaders MALDI-MS CBmed Contact:

      Add to Reading List

      Source URL: www.cbmed.org

      Language: English - Date: 2016-07-05 08:05:00
      4Translating Genomes | Personalizing Medicine rAAV human gene editing, isogenic human disease models, phenotypic cellbased assays for precision functional genomics and targeted drug discovery  400 peer reviewed publica

      Translating Genomes | Personalizing Medicine rAAV human gene editing, isogenic human disease models, phenotypic cellbased assays for precision functional genomics and targeted drug discovery  400 peer reviewed publica

      Add to Reading List

      Source URL: www.summitpharma.co.jp

      Language: English - Date: 2013-03-28 07:55:46
      5Personalized Medicine and Companion Diagnostics: Shaping the Future of the Clinical Research Enterprise PEER REVIEWED | Heather Harris, MSc [DOI: CR]

      Personalized Medicine and Companion Diagnostics: Shaping the Future of the Clinical Research Enterprise PEER REVIEWED | Heather Harris, MSc [DOI: CR]

      Add to Reading List

      Source URL: www.acrpnet.org

      Language: English - Date: 2015-07-17 12:40:21
      6APPLIED PROTEOMICS APPOINTS PREMAL S. SHAH AS VICE PRESIDENT OF BUSINESS DEVELOPMENT San Diego, CA – November 19, 2013 Applied Proteomics Inc. (API), the leading developer of protein-based molecular diagnostics, announ

      APPLIED PROTEOMICS APPOINTS PREMAL S. SHAH AS VICE PRESIDENT OF BUSINESS DEVELOPMENT San Diego, CA – November 19, 2013 Applied Proteomics Inc. (API), the leading developer of protein-based molecular diagnostics, announ

      Add to Reading List

      Source URL: www.appliedproteomics.com

      Language: English - Date: 2016-01-26 21:11:19
      7Clinical Chemistry 54:8 e1–e10Special Report  National Academy of Clinical

      Clinical Chemistry 54:8 e1–e10Special Report National Academy of Clinical

      Add to Reading List

      Source URL: ticino.labmed.ch

      Language: English - Date: 2016-06-27 00:37:39
      8AbsoluteIDQ p180 Kit ® Supporting Biomarker Discovery in Preclinical and Clinical Research

      AbsoluteIDQ p180 Kit ® Supporting Biomarker Discovery in Preclinical and Clinical Research

      Add to Reading List

      Source URL: www.biocrates.com

      Language: English - Date: 2015-10-10 11:23:56
        988  Genome Informatics 17(1): 88{A Statistical Framework for Genome-Wide Discovery of Biomarker Splice Variations with GeneChip Human

        88 Genome Informatics 17(1): 88{A Statistical Framework for Genome-Wide Discovery of Biomarker Splice Variations with GeneChip Human

        Add to Reading List

        Source URL: www.jsbi.org

        Language: English - Date: 2006-09-28 01:48:20
          10Date Posted: Mar 24, 2014  MALDI-MSI: Biomarker Discovery for Radiation Exposures Claire L. Carter1, Thomas J. MacVittie2, Maureen A. Kane1  1. Department of Pharmaceutical Sciences, University of Maryland School of Phar

          Date Posted: Mar 24, 2014 MALDI-MSI: Biomarker Discovery for Radiation Exposures Claire L. Carter1, Thomas J. MacVittie2, Maureen A. Kane1 1. Department of Pharmaceutical Sciences, University of Maryland School of Phar

          Add to Reading List

          Source URL: three.jsc.nasa.gov

          Language: English - Date: 2014-04-01 16:46:30